16% of US Adults Report Psychiatric Drug Use

Share this content:
1 in 6 US adults take a psychiatric medication to treat conditions such as depression, anxiety, and insomnia.
1 in 6 US adults take a psychiatric medication to treat conditions such as depression, anxiety, and insomnia.

HealthDay News — 1 in 6 US adults take a psychiatric medication to treat conditions such as depression, anxiety, and insomnia, according to a study published online Dec. 12 in JAMA Internal Medicine.

Thomas J. Moore, from the Institute for Safe Medication Practices in Alexandria, Va., and Donald R. Mattison, MD, from Risk Sciences International in Ottawa, Canada, used the 2013 US Medical Expenditure Panel Survey to calculate percentages of adults using prescription antidepressants, anti-anxiety drugs, sedatives, sleep aids, and antipsychotics.

Among the 1 in 6 people (16.7%) who reported use of these drugs, 12.0% said they had taken an antidepressant; 8.3% reported filling a prescription for anxiety medicine, sedatives, or sleep aids; and 1.6% said they had taken antipsychotic drugs. White adults were about twice as likely to use these medications (20.8%) as black and Hispanic adults. Just 4.8% of Asians said they had taken them. Among all adults using these drugs, 8 of 10 reported long-term use, meaning 3 or more prescriptions were filled in 2013 or they were continuing a prescription started in 2011 or earlier. Use of these drugs increased with age, with one-quarter of those 60 to 85 reportedly taking them compared to 9% of 18- to 39-year-olds. Women also were more likely to report using psychiatric drugs than men.

Among the 10 leading psychiatric medications were 6 antidepressants: sertraline, citalopram, fluoxetine, trazodone, escitalopram, and duloxetine. Also in the top 10 were 3 anxiety drugs (alprazolam, clonazepam, and lorazepam) and the sleep aid zolpidem, according to the study.

References

Moore TJ, Mattison, DR. Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and RaceJAMA Intern Med. 2016. doi:10.1001/jamainternmed.2016.7507

You must be a registered member of Psychiatry Advisor to post a comment.

Sign Up for Free e-newsletters